Non-Alcoholic Steatohepatitis (NASH) Biomarkers Market to 2024: Trends, Business Strategies and Opportunities
The global NASH biomarkers market is expected to reach a valuation of US$1.7 bn by the end of 2024 as compared to US$201.2 mn in 2016. Between the forecast period of 2016 and 2024, the global market is projected to expand at a CAGR of 31.7%.
View full press release